Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy
Paul W Hardwig1, Amila O Silva2, Jose S Pulido1
1Department of Ophthalmology, Mayo Clinic, Rochester, MN, USA; 2Kaiser Permanente Fontana Medical Center, Fontana, CA, USA
Abstract: Central serous chorioretinopathy (CSCR) is an idiopathic ocular condition – first described in 1866 – that is well known to ophthalmologists. It is less well known to other practitioners. Glucocorticoids have been strongly implicated as a pathogenic factor. We report three patients who developed CSCR following exogenous administration of corticosteroid. Because our patients did not suspect the use of corticosteroid to be important or causative, they did not volunteer the historical detail, and admitted to exogenous corticosteroid injection only with intensive questioning. For their part, physicians should be cognizant of the risk of corticosteroid-induced CSCR, particularly in patients with a prior history of the potentially sight-threatening disease. The development of CSCR is an important iatrogenic and often unrecognized side effect of exogenously administered corticosteroid.
Keywords: exogenous corticosteroid, ocular complication, central serous chorioretinopathy
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.